Column GROUP III Gp, L.P., 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM), bought 125,736 shares at $17.90 ($2.3M) on 2020-03-02, disclosed to the SEC on 2020-03-04.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.90 | 14,124 | $253K | 11.2% |
| 2 | $17.90 | 14,124 | $253K | 11.2% |
| 3 | $17.99 | 38,758 | $697K | 30.9% |
| 4 | $17.99 | 38,758 | $697K | 30.9% |
| 5 | $17.96 | 9,986 | $179K | 7.9% |
| 6 | $17.96 | 9,986 |
| $179K |
| 7.9% |
| Total | $17.97 avg | 125,736 | $2.3M | 100% |
| Filing → |
| TNYA | SELL | 2026-02-12 | $3.0M | — | Filing → |
| SRZN | BUY | 2026-01-20 | $642K | — | Filing → |
| SRZN | BUY | 2026-01-08 | $300K | — | Filing → |